Skip to main content

Peer Review reports

From: Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate

Original Submission
6 Feb 2012 Submitted Original manuscript
4 Apr 2012 Author responded Author comments - Mohamed Ibrahim
Resubmission - Version 2
4 Apr 2012 Submitted Manuscript version 2
14 Jul 2012 Reviewed Reviewer Report - claudio campa
16 Jul 2012 Reviewed Reviewer Report - Stephan Michels
11 Sep 2012 Author responded Author comments - Mohamed Ibrahim
Resubmission - Version 3
11 Sep 2012 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
27 Sep 2012 Reviewed Reviewer Report - claudio campa
28 Sep 2012 Reviewed Reviewer Report - Stephan Michels
28 Oct 2012 Author responded Author comments - Mohamed Ibrahim
Resubmission - Version 5
28 Oct 2012 Submitted Manuscript version 5
31 Dec 2012 Author responded Author comments - Mohamed Ibrahim
Resubmission - Version 6
31 Dec 2012 Submitted Manuscript version 6
Publishing
2 Jan 2013 Editorially accepted
14 Jan 2013 Article published 10.1186/2050-6511-14-7

You can find further information about peer review here.

Back to article page